May 2023 – The Lancet’s eClinicalMedicine AOBiome announces the publication of positive Phase 2b results in The Lancet’s eClinicalMedicine for B244 in the treatment of mild-to-moderate atopic dermatitis and moderate-to-severe pruritus July 2021 – Nature’s Scientific Reports The ammonia oxidizing bacterium Nitrosomonas eutropha blocks T helper 2 cell polarization via the anti-inflammatory cytokine IL-10 March 2018 – Journal of Drugs in Dermatology Dermal Microflora Restoration With Ammonia-Oxidizing Bacteria Nitrosomonas Eutropha in the Treatment of Keratosis Pilaris: A Randomized Clinical Trial November 2014 – Journal of the Nitric Oxide Society Ammonia-oxidizing bacteria accelerate wound closure in diabetic mice June 2019 – Journal of Cosmetic Dermatology The use of topical Nitrosomonas eutropha for cosmetic improvement of facial wrinkles